In memory of Dr. Hans Solinger, M.D.


It is with great sadness that we announce the passing of Hans Solinger, MD, Ph.D., FACS, on May 15, 2023. He was his 76th.

Dr. Solinger received his M.D. and Ph.D. He graduated with honors from the University of Munich in 1974 and he graduated in 1975. His transplant surgery practice at the University of Wisconsin spanned his 40 years. He completed his surgical training in 1980 and was hired by Volkert his Dr. Belzer to join the faculty shortly after training. From 1995 until 2009 he served as chairman of the Department of Transplantation.

Hans Solinger, MD, PhD, FACS

In 1996 Dr. Solinger was elected President of the American Society of Transplant Surgeons (ASTS) and in 1997 President of the International Association for Organ Donation and Sourcing. He was a member of the Surgery, Anesthesiology and Trauma Research Section at the National Institutes of Health from 1994 to 1997. In 2001, he was appointed by Health and Human Services Secretary Tommy Thompson to serve on the Advisory Committee on Organ Transplantation for a four-year term, during which he served as chairman for one year.

Dr. Solinger received the American Society for Transplantation Mentoring Award in 2010 and the 2011 American Society of Transplant Surgeons’ Frances Moore Transplant Surgery Distinguished Teaching Award, and has been recognized by the Society for Transplantation for his outstanding achievements in transplant science (clinical). Winner of the Roche Award. ) received his PhD in 2012. In 2019 he received the prestigious ASTS Pioneer Award. Other honors include Fellowship of the Wisconsin Academy of Arts and Sciences, First Honorary Member of the German Society for Transplantation, and University of Wisconsin Alumni Award of Excellence.

Dr. Solinger’s contributions to the transplant field are numerous. He pioneered the introduction of bladder drainage for pancreas transplantation. He played a central role in the preclinical and clinical development of mycophenolate mofetil, an immunosuppressive drug aimed at reducing organ rejection rates. He was the first surgeon to use his UW solution for pancreas preservation and the first to perform 1,000 simultaneous kidney and pancreas transplants. Later in his career, he led efforts to diagnose and perform therapeutic renal autografts for patients with lumbar hematuria syndrome.

He was deeply committed to the well-being of his patients in order to bring them a better life through transplantation. The admiration he received from patients for his compassionate care was equally strong.

Over the past two decades, Dr. Solinger’s research interests have focused on gene therapy for type 1 diabetes and prevention of post-transplant fibrosis. Towards the end of Dr. Solinger’s career, Dr. Solinger’s lab demonstrated for the first time perfect glucose control in diabetic animals treated with gene therapy.

In addition to his long list of academic and leadership achievements, Dr. Solinger remained passionate and committed to training future transplant surgeons. During his tenure at the University of Wisconsin, he developed and maintained one of the nation’s leading transplant surgery fellowship training programs, which he began in 1984. Throughout his career he has developed 59 transplant surgery fellows, several of whom have become influential leaders in academia. transplant surgery. In addition, many companions became his best friends. His daughters often spoke of the peers he trained, and recalls that they seemed like a growing family.

Dr. Solinger’s name will be greatly missed and his achievements and legacy will forever be remembered.

Click here to read Dr. Solinger’s full obituary.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *